BMO Capital Markets Raises Omega Healthcare Investors (NYSE:OHI) Price Target to $45.00

Omega Healthcare Investors (NYSE:OHI) had its target price hoisted by BMO Capital Markets from $44.00 to $45.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a market perform rating on the real estate investment trust’s stock.

Several other equities research analysts have also recently weighed in on OHI. Mizuho cut Omega Healthcare Investors from an outperform rating to a neutral rating and increased their target price for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a hold rating in a report on Wednesday, September 4th. Wells Fargo & Company restated an overweight rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, Scotiabank increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a sector perform rating in a report on Monday, August 26th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors has a consensus rating of Hold and an average price target of $37.00.

Omega Healthcare Investors Price Performance

OHI opened at $39.56 on Monday. The stock has a 50-day moving average price of $39.28 and a 200-day moving average price of $34.81. Omega Healthcare Investors has a 12-month low of $27.53 and a 12-month high of $41.53. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of $10.20 billion, a P/E ratio of 30.20, a PEG ratio of 1.28 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same quarter in the previous year, the company posted $0.74 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 17.5% compared to the same quarter last year. Equities analysts predict that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Monday, August 5th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.77%. The ex-dividend date of this dividend was Monday, August 5th. Omega Healthcare Investors’s payout ratio is 204.58%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Burns Matteson Capital Management LLC increased its position in Omega Healthcare Investors by 0.7% during the 3rd quarter. Burns Matteson Capital Management LLC now owns 95,710 shares of the real estate investment trust’s stock valued at $3,895,000 after buying an additional 686 shares in the last quarter. UMB Bank n.a. increased its position in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares in the last quarter. CWM LLC increased its position in Omega Healthcare Investors by 234.3% during the 3rd quarter. CWM LLC now owns 13,618 shares of the real estate investment trust’s stock valued at $554,000 after buying an additional 9,545 shares in the last quarter. Royal Fund Management LLC increased its position in Omega Healthcare Investors by 87.4% during the 3rd quarter. Royal Fund Management LLC now owns 60,734 shares of the real estate investment trust’s stock valued at $2,473,000 after buying an additional 28,329 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in Omega Healthcare Investors by 43.1% during the 3rd quarter. GAMMA Investing LLC now owns 3,500 shares of the real estate investment trust’s stock valued at $142,000 after buying an additional 1,054 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.